- Home
- ASPS vs ECOR Comparison
ASPS vs ECOR Comparison
Compare ASPS & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASPS | ECOR |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.0M | 52.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ASPS | ECOR |
|---|---|---|
| Price | $5.87 | $6.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $22.00 |
| AVG Volume (30 Days) | 28.8K | ★ 71.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $38.29 | $28.92 |
| Revenue Next Year | N/A | $32.50 |
| P/E Ratio | $876.47 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.30 | $4.16 |
| 52 Week High | $15.96 | $19.49 |
Technical Indicators
Market Signals| Indicator | ASPS | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 48.11 | 53.68 |
| Support Level | $4.95 | $5.15 |
| Resistance Level | $6.02 | $6.89 |
| Average True Range (ATR) | 0.59 | 0.62 |
| MACD | 0.11 | -0.06 |
| Stochastic Oscillator | 74.12 | 47.25 |
Price Performance
Historical ComparisonAbout ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments, namely Servicer and Real Estate, which derive maximum revenue, and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource mainly serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of its revenue flowing from field services and mortgage and real estate solutions.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.